CN107548393B - 适用于治疗癌症的1-(环)烷基吡啶-2-酮的三环稠合衍生物 - Google Patents
适用于治疗癌症的1-(环)烷基吡啶-2-酮的三环稠合衍生物 Download PDFInfo
- Publication number
- CN107548393B CN107548393B CN201680020269.3A CN201680020269A CN107548393B CN 107548393 B CN107548393 B CN 107548393B CN 201680020269 A CN201680020269 A CN 201680020269A CN 107548393 B CN107548393 B CN 107548393B
- Authority
- CN
- China
- Prior art keywords
- oxo
- methyl
- methoxy
- benzo
- azepin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1636CH2015 | 2015-03-30 | ||
| IN1636/CHE/2015 | 2015-03-30 | ||
| PCT/IN2016/050098 WO2016157221A1 (en) | 2015-03-30 | 2016-03-30 | Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107548393A CN107548393A (zh) | 2018-01-05 |
| CN107548393B true CN107548393B (zh) | 2021-03-02 |
Family
ID=56015058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680020269.3A Active CN107548393B (zh) | 2015-03-30 | 2016-03-30 | 适用于治疗癌症的1-(环)烷基吡啶-2-酮的三环稠合衍生物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10689390B2 (https=) |
| EP (1) | EP3277683B1 (https=) |
| JP (1) | JP6764877B2 (https=) |
| KR (1) | KR102588109B1 (https=) |
| CN (1) | CN107548393B (https=) |
| AU (1) | AU2016242473B2 (https=) |
| BR (1) | BR112017020739B1 (https=) |
| CA (1) | CA2980266C (https=) |
| DK (1) | DK3277683T3 (https=) |
| ES (1) | ES2911886T3 (https=) |
| IL (1) | IL254528B (https=) |
| MX (1) | MX376112B (https=) |
| PL (1) | PL3277683T3 (https=) |
| PT (1) | PT3277683T (https=) |
| RU (1) | RU2721120C2 (https=) |
| WO (1) | WO2016157221A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100277T1 (it) * | 2015-09-09 | 2021-07-12 | Jubilant Biosys Ltd | Derivati triciclici fusi di piridina-2-0ne e loro uso come inibitori di brd4 |
| CA3045855A1 (en) * | 2016-11-10 | 2018-05-17 | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereof |
| WO2019214399A1 (zh) * | 2018-05-10 | 2019-11-14 | 罗欣药业(上海)有限公司 | 苯并七元杂环类化合物、其制备方法、药物组合物及应用 |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| US12527741B2 (en) | 2021-06-17 | 2026-01-20 | Wisconsin Alumni Research Foundation | Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545767A (en) * | 1976-06-30 | 1979-05-16 | Aspro Nicholas Ltd | Isoquinoline derivatives |
| WO2008133288A1 (ja) | 2007-04-25 | 2008-11-06 | Daiichi Sankyo Company, Limited | 三環性アリール化合物 |
| ES2480994T3 (es) | 2008-03-31 | 2014-07-29 | Genentech, Inc. | Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso |
| US9085582B2 (en) | 2010-06-22 | 2015-07-21 | Glaxosmithkline Llc | Benzotriazolodiazepine compounds inhibitors of bromodomains |
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| CA2901352A1 (en) * | 2013-02-19 | 2014-08-28 | Bayer Pharma Aktiengesellschaft | Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines |
| WO2014139324A1 (en) * | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Tetracyclic bromodomain inhibitors |
| WO2015018520A1 (en) | 2013-08-06 | 2015-02-12 | Oncoethix Sa | A bet-brd inhibitor represents a novel agent for alk positive anaplastic large cell lymphoma |
| US9814728B2 (en) * | 2013-09-20 | 2017-11-14 | Saint Louis University | Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi) |
-
2016
- 2016-03-30 AU AU2016242473A patent/AU2016242473B2/en active Active
- 2016-03-30 PL PL16723536T patent/PL3277683T3/pl unknown
- 2016-03-30 MX MX2017012387A patent/MX376112B/es active IP Right Grant
- 2016-03-30 CA CA2980266A patent/CA2980266C/en active Active
- 2016-03-30 US US15/562,381 patent/US10689390B2/en active Active
- 2016-03-30 KR KR1020177031273A patent/KR102588109B1/ko active Active
- 2016-03-30 DK DK16723536.5T patent/DK3277683T3/da active
- 2016-03-30 RU RU2017135205A patent/RU2721120C2/ru active
- 2016-03-30 EP EP16723536.5A patent/EP3277683B1/en active Active
- 2016-03-30 PT PT167235365T patent/PT3277683T/pt unknown
- 2016-03-30 ES ES16723536T patent/ES2911886T3/es active Active
- 2016-03-30 BR BR112017020739-7A patent/BR112017020739B1/pt active IP Right Grant
- 2016-03-30 WO PCT/IN2016/050098 patent/WO2016157221A1/en not_active Ceased
- 2016-03-30 JP JP2017551712A patent/JP6764877B2/ja active Active
- 2016-03-30 CN CN201680020269.3A patent/CN107548393B/zh active Active
-
2017
- 2017-09-17 IL IL254528A patent/IL254528B/en active IP Right Grant
-
2020
- 2020-05-07 US US16/869,517 patent/US11319326B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3277683B1 (en) | 2022-03-09 |
| JP2018510203A (ja) | 2018-04-12 |
| NZ735972A (en) | 2024-08-30 |
| KR102588109B1 (ko) | 2023-10-12 |
| AU2016242473A1 (en) | 2017-10-26 |
| DK3277683T3 (en) | 2022-05-02 |
| PL3277683T3 (pl) | 2022-05-23 |
| CN107548393A (zh) | 2018-01-05 |
| US11319326B2 (en) | 2022-05-03 |
| RU2017135205A (ru) | 2019-04-10 |
| BR112017020739A2 (pt) | 2018-07-17 |
| PT3277683T (pt) | 2022-06-28 |
| MX376112B (es) | 2025-03-07 |
| IL254528B (en) | 2020-11-30 |
| EP3277683A1 (en) | 2018-02-07 |
| IL254528A0 (en) | 2017-11-30 |
| RU2017135205A3 (https=) | 2019-07-17 |
| RU2721120C2 (ru) | 2020-05-15 |
| BR112017020739B1 (pt) | 2023-03-14 |
| US20200331926A1 (en) | 2020-10-22 |
| ES2911886T3 (es) | 2022-05-23 |
| US20180282345A1 (en) | 2018-10-04 |
| CA2980266A1 (en) | 2016-10-06 |
| JP6764877B2 (ja) | 2020-10-07 |
| US10689390B2 (en) | 2020-06-23 |
| AU2016242473B2 (en) | 2020-06-25 |
| HK1248686A1 (zh) | 2018-10-19 |
| MX2017012387A (es) | 2018-06-11 |
| KR20170132278A (ko) | 2017-12-01 |
| WO2016157221A1 (en) | 2016-10-06 |
| CA2980266C (en) | 2025-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI771630B (zh) | 溴結構域(bromodomain)抑制劑 | |
| CN105884780B (zh) | 多环化合物、其药物组合物及应用 | |
| US11319326B2 (en) | Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer | |
| US11267820B2 (en) | Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors | |
| CN110461849A (zh) | 一种csf1r抑制剂及其制备方法和应用 | |
| CA3223874A1 (en) | Pyrimidine compounds for use as map4k1 inhibitors | |
| HK1248686B (zh) | 适用於治疗癌症的1-(环)烷基吡啶-2-酮的三环稠合衍生物 | |
| HK1251562B (zh) | 三环稠合吡啶-2-酮衍生物及其作为brd4抑制剂的用途 | |
| BR112018004338B1 (pt) | Derivados de piridin-2-ona tricíclica fundida, composição, método e seu uso como inibidores de brd4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1248686 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |